Calculated Cell-specific Intracellular Hydrogen Peroxide Concentration: Relevance in Cancer Cell Susceptibility During Ascorbate Therapy

Overview

Journal Free Radic Biol Med

Specialties Biochemistry
Biology
General Medicine

Date 2018 Mar 31

PMID 29601946

Citations 8

Authors

Dieanira Erudaitius

Jacqueline Mantooth

Andrew Huang

Jesse Soliman

Claire M Doskey

Garry R Buettner

Victor G J Rodgers

Affiliations

Soon will be listed here.

Abstract

The high extracellular hydrogen peroxide (HO) concentrations generated during pharmacological ascorbate (P-AscH) therapy has been shown to exhibit a high flux into susceptible cancer cells leading to a decrease in clonogenic survival. It is hypothesized that the intracellular HO concentration for susceptibility is independent of cell type and that the variation observed in dosing is associated with differences in the cell-specific overall steady-state intracellular HO concentration values. The steady-state variation in intracellular HO concentration is coupled to a number of cellular specific transport and reaction factors including catalase activity and membrane permeability. Here a lumped-parameter mathematical modeling approach, assuming a catalase-dominant peroxide removal mechanism, is used to calculate intracellular HO concentration for several cell lines. Experimental measurements of critical parameters pertaining to the model are obtained. The cell lines investigated are normal pancreatic cells, H6c7, the pancreatic cancer cell line, MIA PaCa-2 and the glioblastoma cell lines, LN-229, T98G, and U-87; all which vary in susceptibility. The intracellular HO concentration estimates are correlated with the clonogenic surviving fraction for each cell line, in-vitro. The results showed that, despite the fact that the experimental parameters including catalase concentration and plasma membrane permeability demonstrated significant variability across cell lines, the calculated steady-state intracellular to extracellular HO concentration ratio did not vary significantly across cell lines. Thus, the calculated intracellular HO concentration is not unique in characterizing susceptibility. These results imply that, although intracellular HO concentration plays a key role in cellular susceptibility to P-AscH adjuvant therapy, its overall contribution in a unifying mechanism across cell types is complex.

Citing Articles

Pharmacological ascorbate combined with rucosopasem selectively radio-chemo-sensitizes NSCLC via generation of HO.

Pulliam C, Fath M, Sho S, Johnson S, Wagner B, Singhania M Redox Biol. 2025; 80:103505.

PMID: 39884000 PMC: 11830350. DOI: 10.1016/j.redox.2025.103505.

Balanced Duality: HO-Based Therapy in Cancer and Its Protective Effects on Non-Malignant Tissues.

Zaher A, Petronek M, Allen B, Mapuskar K Int J Mol Sci. 2024; 25(16).

PMID: 39201571 PMC: 11354297. DOI: 10.3390/ijms25168885.

Relevant Membrane Transport Proteins as Possible Gatekeepers for Effective Pharmacological Ascorbate Treatment in Cancer.

Leischner C, Marongiu L, Piotrowsky A, Niessner H, Venturelli S, Burkard M Antioxidants (Basel). 2023; 12(4).

PMID: 37107291 PMC: 10135768. DOI: 10.3390/antiox12040916.

Ascorbate as a Bioactive Compound in Cancer Therapy: The Old Classic Strikes Back.

Gonzalez-Montero J, Chichiarelli S, Eufemi M, Altieri F, Saso L, Rodrigo R Molecules. 2022; 27(12).

PMID: 35744943 PMC: 9229419. DOI: 10.3390/molecules27123818.

The Quest to Quantify Selective and Synergistic Effects of Plasma for Cancer Treatment: Insights from Mathematical Modeling.

Bengtson C, Bogaerts A Int J Mol Sci. 2021; 22(9).

PMID: 34068601 PMC: 8126141. DOI: 10.3390/ijms22095033.

References

Rawal M, Schroeder S, Wagner B, Cushing C, Welsh J, Button A . Manganoporphyrins increase ascorbate-induced cytotoxicity by enhancing H2O2 generation. Cancer Res. 2013; 73(16):5232-41. PMC: 3745518. DOI: 10.1158/0008-5472.CAN-13-0470. View

Chen Q, Espey M, Krishna M, Mitchell J, Corpe C, Buettner G . Pharmacologic ascorbic acid concentrations selectively kill cancer cells: action as a pro-drug to deliver hydrogen peroxide to tissues. Proc Natl Acad Sci U S A. 2005; 102(38):13604-9. PMC: 1224653. DOI: 10.1073/pnas.0506390102. View

Moser J, Rawal M, Wagner B, Du J, Cullen J, Buettner G . Pharmacological ascorbate and ionizing radiation (IR) increase labile iron in pancreatic cancer. Redox Biol. 2014; 2:22-7. PMC: 3881203. DOI: 10.1016/j.redox.2013.11.005. View

Makino N, Sasaki K, Hashida K, Sakakura Y . A metabolic model describing the H2O2 elimination by mammalian cells including H2O2 permeation through cytoplasmic and peroxisomal membranes: comparison with experimental data. Biochim Biophys Acta. 2004; 1673(3):149-59. DOI: 10.1016/j.bbagen.2004.04.011. View

Franken N, Rodermond H, Stap J, Haveman J, van Bree C . Clonogenic assay of cells in vitro. Nat Protoc. 2007; 1(5):2315-9. DOI: 10.1038/nprot.2006.339. View

Schoenfeld J, Sibenaller Z, Mapuskar K, Wagner B, Cramer-Morales K, Furqan M . O and HO-Mediated Disruption of Fe Metabolism Causes the Differential Susceptibility of NSCLC and GBM Cancer Cells to Pharmacological Ascorbate. Cancer Cell. 2017; 32(2):268. DOI: 10.1016/j.ccell.2017.07.008. View

Welsh J, Wagner B, vant Erve T, Zehr P, Berg D, Halfdanarson T . Pharmacological ascorbate with gemcitabine for the control of metastatic and node-positive pancreatic cancer (PACMAN): results from a phase I clinical trial. Cancer Chemother Pharmacol. 2013; 71(3):765-75. PMC: 3587047. DOI: 10.1007/s00280-013-2070-8. View

Cieslak J, Strother R, Rawal M, Du J, Doskey C, Schroeder S . Manganoporphyrins and ascorbate enhance gemcitabine cytotoxicity in pancreatic cancer. Free Radic Biol Med. 2015; 83:227-37. PMC: 4441864. DOI: 10.1016/j.freeradbiomed.2015.02.018. View

Klingelhoeffer C, Kammerer U, Koospal M, Muhling B, Schneider M, Kapp M . Natural resistance to ascorbic acid induced oxidative stress is mainly mediated by catalase activity in human cancer cells and catalase-silencing sensitizes to oxidative stress. BMC Complement Altern Med. 2012; 12:61. PMC: 3404974. DOI: 10.1186/1472-6882-12-61. View

10.

AEBI H . Catalase in vitro. Methods Enzymol. 1984; 105:121-6. DOI: 10.1016/s0076-6879(84)05016-3. View

11.

Lipinski P, Drapier J, Oliveira L, Retmanska H, Sochanowicz B, Kruszewski M . Intracellular iron status as a hallmark of mammalian cell susceptibility to oxidative stress: a study of L5178Y mouse lymphoma cell lines differentially sensitive to H(2)O(2). Blood. 2000; 95(9):2960-6. View

12.

Chen Q, Espey M, Sun A, Pooput C, Kirk K, Krishna M . Pharmacologic doses of ascorbate act as a prooxidant and decrease growth of aggressive tumor xenografts in mice. Proc Natl Acad Sci U S A. 2008; 105(32):11105-9. PMC: 2516281. DOI: 10.1073/pnas.0804226105. View

13.

Lim J, Huang B, Deen W, Sikes H . Analysis of the lifetime and spatial localization of hydrogen peroxide generated in the cytosol using a reduced kinetic model. Free Radic Biol Med. 2015; 89:47-53. DOI: 10.1016/j.freeradbiomed.2015.07.009. View

14.

Miller E, Dickinson B, Chang C . Aquaporin-3 mediates hydrogen peroxide uptake to regulate downstream intracellular signaling. Proc Natl Acad Sci U S A. 2010; 107(36):15681-6. PMC: 2936599. DOI: 10.1073/pnas.1005776107. View

15.

Castro M, McConnell M, Herst P . Radiosensitisation by pharmacological ascorbate in glioblastoma multiforme cells, human glial cells, and HUVECs depends on their antioxidant and DNA repair capabilities and is not cancer specific. Free Radic Biol Med. 2014; 74:200-9. DOI: 10.1016/j.freeradbiomed.2014.06.022. View

16.

Du J, Cullen J, Buettner G . Ascorbic acid: chemistry, biology and the treatment of cancer. Biochim Biophys Acta. 2012; 1826(2):443-57. PMC: 3608474. DOI: 10.1016/j.bbcan.2012.06.003. View

17.

Erudaitius D, Huang A, Kazmi S, Buettner G, Rodgers V . Peroxiporin Expression Is an Important Factor for Cancer Cell Susceptibility to Therapeutic H2O2: Implications for Pharmacological Ascorbate Therapy. PLoS One. 2017; 12(1):e0170442. PMC: 5249139. DOI: 10.1371/journal.pone.0170442. View

18.

Du J, Wagner B, Buettner G, Cullen J . Role of labile iron in the toxicity of pharmacological ascorbate. Free Radic Biol Med. 2015; 84:289-295. PMC: 4739508. DOI: 10.1016/j.freeradbiomed.2015.03.033. View

19.

Chen P, Yu J, Chalmers B, Drisko J, Yang J, Li B . Pharmacological ascorbate induces cytotoxicity in prostate cancer cells through ATP depletion and induction of autophagy. Anticancer Drugs. 2011; 23(4):437-44. DOI: 10.1097/CAD.0b013e32834fd01f. View

20.

Antunes F, Cadenas E . Estimation of H2O2 gradients across biomembranes. FEBS Lett. 2000; 475(2):121-6. DOI: 10.1016/s0014-5793(00)01638-0. View